Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
1(13%)
Results Posted
40%(2 trials)
Terminated
1(13%)

Phase Distribution

Ph not_applicable
6
75%
Ph phase_2
1
13%
Ph phase_3
1
13%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(5)
Terminated(1)

Detailed Status

Completed5
Not yet recruiting1
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (12.5%)
Phase 31 (12.5%)
N/A6 (75.0%)

Trials by Status

not_yet_recruiting113%
terminated113%
completed563%
recruiting113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8